Initial Approach to Treating Hyponatremia
The initial approach to treating hyponatremia must be determined by symptom severity and volume status, with severely symptomatic patients requiring immediate 3% hypertonic saline to correct sodium by 6 mmol/L over 6 hours, while asymptomatic patients require careful assessment of volume status to guide therapy—never exceeding 8 mmol/L correction in 24 hours to prevent osmotic demyelination syndrome. 1
Immediate Assessment: Symptom Severity Determines Urgency
Severe Symptomatic Hyponatremia (Medical Emergency)
Severe symptoms include seizures, coma, altered mental status, confusion, or cardiorespiratory distress—these require immediate intervention regardless of sodium level 1, 2:
- Administer 3% hypertonic saline immediately as 100-150 mL IV bolus over 10 minutes, repeatable up to three times at 10-minute intervals until symptoms improve 1, 3
- Target correction: 6 mmol/L over first 6 hours or until severe symptoms resolve 1
- Absolute maximum: 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome 1, 2
- Monitor serum sodium every 2 hours during initial correction phase 1
Asymptomatic or Mildly Symptomatic Hyponatremia
Mild symptoms include nausea, vomiting, headache, or weakness—these allow time for diagnostic workup 3:
- Proceed with volume status assessment before initiating treatment 1
- Correction can be more gradual (4-6 mmol/L per day) 1
- Monitor sodium every 24 hours initially 1
Essential Diagnostic Workup (Performed Concurrently with Treatment)
Obtain these tests immediately to determine underlying cause 1:
- Serum osmolality to exclude pseudohyponatremia 1
- Urine osmolality and urine sodium concentration to differentiate causes 1
- Serum and urine electrolytes including potassium 1
- Assess extracellular fluid volume status through physical examination 1
Volume Status Assessment (Critical for Treatment Selection)
Hypovolemic signs (true volume depletion) 1:
- Orthostatic hypotension, dry mucous membranes, decreased skin turgor, flat neck veins
- Urine sodium <30 mmol/L predicts saline responsiveness (71-100% positive predictive value) 1
Euvolemic signs (SIADH most common) 1:
- No edema, normal blood pressure, moist mucous membranes
- Urine sodium >20-40 mmol/L with urine osmolality >300 mOsm/kg
- Serum uric acid <4 mg/dL has 73-100% positive predictive value for SIADH 1
Hypervolemic signs (heart failure, cirrhosis) 1:
- Peripheral edema, ascites, jugular venous distention, pulmonary congestion
Treatment Algorithm Based on Volume Status
Hypovolemic Hyponatremia
Primary treatment: Volume repletion with isotonic saline 1, 3:
- Administer 0.9% normal saline (154 mEq/L sodium) for volume restoration 1
- Initial infusion rate: 15-20 mL/kg/h, then 4-14 mL/kg/h based on response 1
- Discontinue diuretics immediately if sodium <125 mmol/L 1
- Maximum correction: 8 mmol/L in 24 hours 1
Euvolemic Hyponatremia (SIADH)
Primary treatment: Fluid restriction 1, 3:
- Fluid restriction to 1 L/day is the cornerstone of treatment 1
- If no response to fluid restriction after 24-48 hours, add oral sodium chloride 100 mEq three times daily 1
- For severe symptoms: 3% hypertonic saline with target correction of 6 mmol/L over 6 hours 1
- Pharmacological options for resistant cases 1, 4:
Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)
Primary treatment: Fluid restriction and treat underlying condition 1, 3:
- Fluid restriction to 1-1.5 L/day for sodium <125 mmol/L 1
- Discontinue diuretics temporarily if sodium <125 mmol/L 1
- For cirrhotic patients: Consider albumin infusion alongside fluid restriction 1
- Avoid hypertonic saline unless life-threatening symptoms present—it worsens ascites and edema 1
- Vaptans may be considered for persistent severe hyponatremia despite fluid restriction 4
Critical Correction Rate Guidelines
Standard correction rates 1:
- Maximum 8 mmol/L in 24 hours for all patients 1, 2
- Target 4-8 mmol/L per day for average-risk patients 1
High-risk patients require slower correction (4-6 mmol/L per day, maximum 8 mmol/L in 24 hours) 1:
- Advanced liver disease, alcoholism, malnutrition
- Severe hyponatremia (<120 mmol/L)
- Prior encephalopathy
- Hypophosphatemia, hypokalemia
Special Considerations and Common Pitfalls
Neurosurgical Patients: Distinguish SIADH from Cerebral Salt Wasting (CSW)
This distinction is critical as treatments are opposite 1:
SIADH characteristics 1:
- Euvolemic state, normal to slightly elevated CVP
- Urine sodium >20-40 mmol/L, urine osmolality >500 mOsm/kg
- Treatment: Fluid restriction
CSW characteristics 1:
- True hypovolemia, CVP <6 cm H₂O
- Urine sodium >20 mmol/L despite volume depletion
- Clinical signs of volume depletion
- Treatment: Volume and sodium replacement with normal saline or 3% hypertonic saline, NEVER fluid restriction 1
- Consider fludrocortisone 0.1-0.2 mg daily for severe symptoms 1
Avoid These Common Pitfalls
- Never use fluid restriction in CSW—it worsens outcomes 1
- Never exceed 8 mmol/L correction in 24 hours—risks osmotic demyelination syndrome 1, 2
- Never ignore mild hyponatremia (130-135 mmol/L)—associated with increased falls (21% vs 5%) and 60-fold increased mortality 1, 2
- Never use hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms 1
- Inadequate monitoring during active correction is dangerous 1
- Failing to recognize and treat the underlying cause leads to recurrence 1
Management of Overcorrection
If sodium correction exceeds 8 mmol/L in 24 hours 1:
- Immediately discontinue current fluids and switch to D5W (5% dextrose in water) 1
- Consider administering desmopressin to slow or reverse rapid rise 1
- Monitor for osmotic demyelination syndrome signs (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically occurring 2-7 days after rapid correction 1